These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

3682 related items for PubMed ID: 12208749

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
    Gougelet A, Bouclier C, Marsaud V, Maillard S, Mueller SO, Korach KS, Renoir JM.
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
    [Abstract] [Full Text] [Related]

  • 5. Effect of estrogen, tamoxifen and epidermal growth factor on the transcriptional regulation of vascular endothelial growth factor in breast cancer cells.
    Lee JE, Chung KW, Han W, Kim SW, Kim SW, Shin HJ, Bae JY, Noh DY.
    Anticancer Res; 2004 Feb; 24(6):3961-4. PubMed ID: 15736439
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.
    Kawai H, Li H, Chun P, Avraham S, Avraham HK.
    Oncogene; 2002 Oct 31; 21(50):7730-9. PubMed ID: 12400015
    [Abstract] [Full Text] [Related]

  • 8. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
    Kinoshita Y, Chen S.
    Cancer Res; 2003 Jul 01; 63(13):3546-55. PubMed ID: 12839940
    [Abstract] [Full Text] [Related]

  • 9. Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma.
    Pal S, Datta K, Mukhopadhyay D.
    Cancer Res; 2001 Sep 15; 61(18):6952-7. PubMed ID: 11559575
    [Abstract] [Full Text] [Related]

  • 10. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
    Chen B, Gajdos C, Dardes R, Kidwai N, Johnston SR, Dowsett M, Jordan VC.
    Int J Oncol; 2005 Aug 15; 27(2):327-35. PubMed ID: 16010412
    [Abstract] [Full Text] [Related]

  • 11. ERbeta sensitizes breast cancer cells to retinoic acid: evidence of transcriptional crosstalk.
    Rousseau C, Nichol JN, Pettersson F, Couture MC, Miller WH.
    Mol Cancer Res; 2004 Sep 15; 2(9):523-31. PubMed ID: 15383631
    [Abstract] [Full Text] [Related]

  • 12. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration.
    Xiong S, Grijalva R, Zhang L, Nguyen NT, Pisters PW, Pollock RE, Yu D.
    Cancer Res; 2001 Feb 15; 61(4):1727-32. PubMed ID: 11245489
    [Abstract] [Full Text] [Related]

  • 13. Prenylation inhibitors stimulate both estrogen receptor alpha transcriptional activity through AF-1 and AF-2 and estrogen receptor beta transcriptional activity.
    Cestac P, Sarrabayrouse G, Médale-Giamarchi C, Rochaix P, Balaguer P, Favre G, Faye JC, Doisneau-Sixou S.
    Breast Cancer Res; 2005 Feb 15; 7(1):R60-70. PubMed ID: 15642170
    [Abstract] [Full Text] [Related]

  • 14. Differential and opposing regulation of PAI-1 promoter activity by estrogen receptor alpha and estrogen receptor beta in endothelial cells.
    Smith LH, Coats SR, Qin H, Petrie MS, Covington JW, Su M, Eren M, Vaughan DE.
    Circ Res; 2004 Aug 06; 95(3):269-75. PubMed ID: 15217907
    [Abstract] [Full Text] [Related]

  • 15. Tamoxifen induces the expression of maspin through estrogen receptor-alpha.
    Liu Z, Shi HY, Nawaz Z, Zhang M.
    Cancer Lett; 2004 Jun 08; 209(1):55-65. PubMed ID: 15145521
    [Abstract] [Full Text] [Related]

  • 16. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
    Gougelet A, Mueller SO, Korach KS, Renoir JM.
    J Steroid Biochem Mol Biol; 2007 May 08; 104(3-5):110-22. PubMed ID: 17478088
    [Abstract] [Full Text] [Related]

  • 17. Activation of vascular endothelial growth factor (VEGF) by the ER-alpha variant, ERDelta3.
    Koduri S, Goldhar AS, Vonderhaar BK.
    Breast Cancer Res Treat; 2006 Jan 08; 95(1):37-43. PubMed ID: 16267616
    [Abstract] [Full Text] [Related]

  • 18. Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3'-kinase and distinct from that induced by hypoxia.
    Maity A, Pore N, Lee J, Solomon D, O'Rourke DM.
    Cancer Res; 2000 Oct 15; 60(20):5879-86. PubMed ID: 11059786
    [Abstract] [Full Text] [Related]

  • 19. Cloning and functional characterization of PELP1/MNAR promoter.
    Mishra SK, Balasenthil S, Nguyen D, Vadlamudi RK.
    Gene; 2004 Apr 14; 330():115-22. PubMed ID: 15087130
    [Abstract] [Full Text] [Related]

  • 20. Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen.
    Hyder SM, Stancel GM, Chiappetta C, Murthy L, Boettger-Tong HL, Makela S.
    Cancer Res; 1996 Sep 01; 56(17):3954-60. PubMed ID: 8752163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 185.